Stocks360

Arctic Bioscience AS (ABS.OL)

Stock analysis · OSL · Healthcare · Biotechnology

Share: Facebook X WhatsApp SMS

Get deeper signals and personalized alerts

Free account signup in under 60 seconds

Create free account → I already have an account
Market Cap
N/A
PE (TTM)
N/A
EPS (TTM)
N/A
Dividend Yield
N/A
Beta
1.10
Day Range
N/A
52-wk Range
N/A
Avg Volume
N/A
Volume
N/A

Arctic Bioscience AS (ABS.OL) is a publicly traded company in the Healthcare sector. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.

Get full analysis → Short-Term Analysis →

Proprietary Signals

Signal snapshot temporarily unavailable.

About Arctic Bioscience AS

Arctic Bioscience AS, a clinical-stage biotechnology company, engages in developing and commercializing pharmaceutical and nutraceutical ingredients based on bioactive marine compounds in Norway, the United States, Europe, and Asia Pacific. The company is developing HRO350, a novel oral drug which is in phase IIb for the treatment of mild-to-moderate psoriasis. It also sells nutraceuticals as intermediary and finished goods products under the ROMEGA brand name. Arctic Bioscience AS was incorporated in 2011 and is headquartered in Ørsta, Norway.

Peers

AIRX.OL
Airthings ASA
$0.13 · $27.14M
BGBIO.OL
BerGenBio ASA
$1.17 · $45.74M
HDLY.OL
Huddly AS
$19.10 · $468.13M

Recent News

  • No recent news available.

Related

Browse more tickers: sitemap